Sign in

CIK 0001841330

  • Emerging growth company

Pasithea Therapeutics Corp.

Sign in to watch
Ticker
KTTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851591963
Phone
+1 702-514-4174
Business address
1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH, FL, 33139
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-17 Coastlands Capital LP 10% owner Purchase +100,000 $0.53 $53K 3,835,035
2026-05-01 Marques Tiago Chief Executive Officer Grant or award · Stock Option (right to buy) +1,756,069 1,756,069
2026-05-01 STEINMAN LAWRENCE Director Grant or award · Stock Option (right to buy) +152,783 152,783
2026-05-01 Dumesnil Simon Director Grant or award · Stock Option (right to buy) +152,783 152,783
2026-05-01 Schneiderman Daniel H Chief Financial Officer Grant or award · Stock Option (right to buy) +1,129,323 1,129,323
2026-05-01 Krishnan Kartik Chief Medical Officer Grant or award · Stock Option (right to buy) +1,129,323 1,129,323
2026-05-01 Leahy Emer Director Grant or award · Stock Option (right to buy) +152,783 152,783
2026-05-01 Novak Alfred J Director Grant or award · Stock Option (right to buy) +152,783 152,783
2025-11-28 STEINMAN LAWRENCE Director Purchase +133,333 $0.75 $100K 199,691
2025-11-28 Schneiderman Daniel H Chief Financial Officer Grant or award +26,667 $0.75 $20K 26,667
2025-11-28 Marques Tiago Chief Executive Officer Purchase +33,333 $0.75 $25K 73,334
2025-11-28 Dumesnil Simon Director Purchase +33,333 $0.75 $25K 35,833
2025-11-28 Leahy Emer Director Grant or award +33,333 $0.75 $25K 33,333
2025-10-24 STEINMAN LAWRENCE Director Grant or award · Stock Option (right to buy) +242,913 242,913
2025-10-24 Schneiderman Daniel H Chief Financial Officer Grant or award · Stock Option (right to buy) +317,266 317,266
2025-10-24 Novak Alfred J Director Grant or award · Stock Option (right to buy) +42,913 42,913
2025-10-24 Marques Tiago Chief Executive Officer Grant or award · Stock Option (right to buy) +493,341 493,341
2025-10-24 Leahy Emer Director Grant or award · Stock Option (right to buy) +42,913 42,913
2025-10-24 Dumesnil Simon Director Grant or award · Stock Option (right to buy) +42,913 42,913
2025-05-12 Marques Tiago Chief Executive Officer Sale −960 $0.83 $792 40,001

Page 1 of 4 · 79 trades